Diabetes - Pharmacist Digest

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

Pharmacy Times

JULY 16, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

HIV Treatment and Prevention Agents

HIV Treatment and Prevention Agents Pharmacy Technician Diabetes Compounding Pharmacies

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Pharmacy Times

JUNE 19, 2025

News All News FDA Updates Press Releases Media All Videos Digital Detail Independent Corner Insights Interviews MEDcast Medical World News Microsites Peer Exchange Perfect Consult Podcasts Practice Pearls Sponsored Webcast Student Voices Webinars/Webcasts Conferences Conference Coverage Conference Listing Publications Pharmacy Times Pharmacy Practice (..)

Insights From ASCO 2025 Guide Pharmacy Practice in Solid Tumors and Hematologic Cancers

New Drugs, New Decisions: How Pharmacists Are Guiding the Future of Hematologic Care

Trending Sources

ADA 2025: Insights into Diabetes, Obesity, and Pharmacist's Role in Advancing Care

IsaKRD Induction Achieves 95% Response Rate in Multiple Myeloma

FDA Removes REMS for Currently Approved BCMA-, CD19-Directed CAR T Cell Immunotherapies

Understanding Recent Changes to 505(b)(2) Drugs and Reimbursement

Real-World Data Shows Similar Clinical Outcomes in Patients Receiving Biosimilars Following Switch From Reference Product

Lumateperone Submits Application for Schizophrenia Indication to FDA for Supplemental New Drug

FDA Approves Vancomycin Injection For Ready-to-Infuse Sepsis Therapy

Zanubrutinib Linked to Lower Infection Risk Than Venetoclax Plus Obinutuzumab in Real-World CLL/SLL Study

FDA Approves Y-90 Resin Microspheres for Unrespectable Hepatocellular Carcinoma

Steroid Use During ICI Treatment Lessens Effectiveness in Patients With NSCLC

FDA Approves Immunoglobulin Formulation With Low IgA Content for Primary Immunodeficiency

CAR T and Beyond: The Expanding Pipeline and Promise of Cell Therapies

Anlotinib Following Benmelstobart Plus Chemotherapy Improves Progression-Free Survival in S-NSCLC

Study Confirms Interchangeability of Hulio, Biosimilar of Humira, in Severe Chronic Plaque Psoriasis

Lorundrostat Shows Clinically Meaningful Outcomes in Patients With CKD and Hypertension

Investigating the Pharmacist’s Role in Psychedelic-Assisted Psychotherapy for Patients With Cancer

Efepoetin Alfa Noninferior to Mircera When Correcting Anemia, Maintaining Hemoglobin in CKD

IAS 2025: Patients With HIV Grapple With Healthy Aging, Reducing CVD Risk

To Combat Medication Errors, Proper Pharmacy Inventory Counts Are Essential

Ropeginterferon Alfa 2b Is Well-Tolerated, Efficacious in Treatment of Prefibrotic Myelofibrosis

FDA Issues Complete Response Letter for Glofit-GemOx in R/R DLBCL

Taletrectinib Gains FDA Approval for Locally Advanced or Metastatic ROS1+ NSCLC

Self-Care Measures for Preventing and Managing Dysmenorrhea

Pharmacists Take the Lead on Advanced Therapeutics

Donanemab-Azbt Receives FDA Label Update With New Dosing for Alzheimer Disease

INCB057643 in Combination with Ruxolitinib Improves Symptoms in Patients With Myelofibrosis

Psychiatric Medication Adherence in Patients Experiencing Homelessness

High Response Rates With Talquetamab Plus Teclistamab in Triple-Class Refractory Multiple Myeloma

Study Suggests Transplant Recipients Are at Greater Risk of Developing RSV

Sequencing of Liposomal Daunorubicin/Cytarabine Versus Hypomethylating Agents Plus Venetoclax for Secondary Acute Myeloid Leukemia

FDA Approves Twice-Yearly Lenacapavir for HIV Preexposure Prophylaxis

OTC Case Studies: Summer Skin Care

Belimumab Autoinjector Receives FDA Approval for Children With Active Lupus Nephritis

ADA 2025: Advancing CGM Adoption for Type 2 Diabetes Care

ASCO 2025: Vepdegestrant Shows Superiority to Fulvestrant in ER+/HER2- Advanced Breast Cancer

ASCO 2025: Promising Safety and Efficacy of Encorafenib and Binimetinib in Resected Stage II Melanoma

TRE-5151 Receives FDA Fast Track Designation in Combination With Radiation Therapy for Prostate Cancer

Navigating EGFR Mutations and ALK Fusions in Early-Stage Non-Small Cell Lung Cancer

The Path to Cervical Cancer Eradication: Overcoming Barriers to HPV Vaccination

Clinical Manifestations of Acute, Chronic Graft-vs-Host Disease With PTCy in Patients Receiving Allogeneic Hematopoietic Stem Cell Transplantation

Study Finds VPS72 Is Overactive in Patients With Hepatocellular Carcinoma

Study Finds Depression May Increase Risk of Developing Dementia

Stay Connected